despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
.
.
.
the software identified and measured a marker of svd and then gave a score indicating how severe the disease was ranging from mild to severe.
.
.
218 Used Today
181 Used Today
200 Used Today